Studies on the stability of the plasma substance P of patients administrated gastrointestinal cancer chemotherapy

Studies on the stability of the plasma substance P of patients administrated gastrointestinal cancer chemotherapy - SP-01

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017595

Enrollment

Registered

2015-05-18

Start date

2015-05-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient age of 20 years or older at the time of obtaining informed consent. Patients after receiving a sufficient explanation Upon participation in this study, on the thorough understanding, that document consent is obtained by the free will of the patient himself. Patients who received the chemotherapy containing oxaliplatin or irinotecan against gastrointestinal cancer.

Exclusion criteria

Exclusion criteria: Patients principal investigator or research personnel was judged unsuitable as subjects

Design outcomes

Primary

Measure	Time frame
The rate of change in time and substance P measurements taken from sample collection to separation and frozen	—

Countries

Japan

Contacts

Public ContactTetsuhito Muranaka

Department of Gastroenterology and Hepatology Department of Gastroenterology and Hepatology

tmuranaka@med.hokudai.ac.jp+81-11-716-1161

Outcome results